How Investors Are Reacting To Ambarella (AMBA) Pivoting Deeper Into Edge AI And Semi-Custom Chips

• Earlier in March 2026, Ambarella outlined its expanding Edge AI strategy at the Cantor Fitzgerald Global Technology and Industrial Growth Conference, revealing that Edge AI now contributes 80% of revenue and grew 50% over the prior year while also launching indirect sales channels and a semi-custom chip program targeting a future two-nanometer design.
• This shift toward a higher-mix Edge AI portfolio, coupled with plans for advanced semi-custom chips, marks a meaningful evolution in how Ambarella aims to reach customers and compete in the AI semiconductor space.
• Next, we’ll explore how Ambarella’s heavier Edge AI revenue mix and semi-custom chip initiative may influence its existing investment narrative.

Find 54 companies with promising cash flow potential yet trading below their fair value.

Ambarella Investment Narrative Recap

To own Ambarella, you need to believe its edge AI platform can turn strong revenue traction into a path toward eventual profitability while managing heavy R&D and customer concentration risks. The latest update that edge AI now represents 80% of revenue and grew 50% year over year supports the core growth thesis, but it does not materially change the near term risk that high IoT and consumer exposure could translate into uneven demand and ongoing losses.

Among recent developments, the semi custom chip initiative tied to a future 2 nanometer design stands out as most relevant. It reinforces Ambarella’s attempt to deepen its position in edge AI and potentially support longer term revenue visibility, even as the company continues to guide for only moderate top line growth and remains unprofitable in the near term. How effectively these advanced designs convert into broad customer adoption is likely to shape the next phase of the story.

However, against the promise of faster edge AI growth, investors should also be aware of the continued risk that rising R&D spending and intense AI SoC competition could...

Read the full narrative on Ambarella (it's free!)

Ambarella's narrative projects $526.3 million revenue and $74.3 million earnings by 2028. This requires 14.8% yearly revenue growth and a $162.9 million earnings increase from $-88.6 million today.

Uncover how Ambarella's forecasts yield a $97.45 fair value, a 80% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts paint a much harsher picture, assuming revenue of about US$490,000,000 by 2028 with no near term profitability, which contrasts sharply with the growth potential implied by Ambarella’s 80 percent edge AI revenue mix and highlights how differently you might weigh today’s edge AI momentum against the risk of persistent losses and pricing pressure.

Explore 6 other fair value estimates on Ambarella - why the stock might be worth just $65.00!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Ambarella research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Ambarella research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ambarella's overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 33 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com